SCHEDULE: Great Point Partners Holds 9.99% Stake in SCYNEXIS

Great Point Partners, LLC, along with Dr. Jeffrey R. Jay, M.D. and Ms. Lillian Nordahl, has reported a beneficial ownership of 9.99% in SCYNEXIS, Inc. common stock as of June 30, 2026.

Summary

• Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl have jointly filed a Schedule 13G, indicating their beneficial ownership of 4,076,068 shares of SCYNEXIS, Inc. common stock.
• This holding represents 9.99% of the class of securities outstanding.
• The filing is an amendment, indicating a change or update to their previous filing.
• The reporting persons are investment adviser (IA), hedge fund (HC), and investment company (IN) types.
• The filing specifies that the aggregate amount beneficially owned excludes certain shares due to a Beneficial Ownership Cap, which restricts exercise of warrants.
• The total number of outstanding shares considered for this filing is 9,930,329, reflecting a 1-for-8 stock split.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant but stable ownership stake without immediate aggressive action.

Positives

• Significant ownership stake of 9.99% indicates strong conviction in SCYNEXIS, Inc.
• The reporting persons are sophisticated investors (investment adviser, hedge fund) which can bring valuable expertise.
• The filing is an amendment, suggesting active management of their investment position.

Negatives

• The Beneficial Ownership Cap limits the ability to fully exercise warrants, capping their effective ownership and potential upside from those instruments.
• The filing does not provide any strategic insights or future plans, making it difficult to assess the intent behind the stake.

Risks

• The Beneficial Ownership Cap restricts the exercise of warrants, meaning that while they hold warrants for more shares, they cannot exercise them if it pushes their ownership over 9.99%.

Future Outlook

The filing does not contain any forward-looking statements or specific guidance regarding future performance or strategy.

Management Comments

• Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl have entered into a Joint Filing Agreement, agreeing to file this statement jointly.
• The reporting persons disclaim beneficial ownership of certain shares except to the extent of their respective pecuniary interests.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes. The 9.99% threshold is often a key level before more detailed disclosures or potential activist engagement might occur, though this filing does not suggest such intent.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which can influence market perception and trading activity.
• Management: The 9.99% ownership by Great Point Partners may signal a level of scrutiny or potential influence on corporate decisions.

Next Steps

• Continued monitoring of Great Point Partners' stake in SCYNEXIS, Inc.
• Observation of any future amendments to this Schedule 13G filing.

Key Dates

Keywords

SCYNEXIS, Schedule 13G, Great Point Partners, beneficial ownership, common stock, warrants, investment adviser, hedge fund